{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:21:15Z","timestamp":1789568475864,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PNPD\/CAPES"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.bbr.2018.06.032","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T19:09:35Z","timestamp":1530212975000},"page":"51-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid \u03b2 (A\u03b21-40) administration in mice"],"prefix":"10.1016","volume":"353","author":[{"given":"Ana C.","family":"Guerra de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinara L.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana M.","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui D.","family":"Prediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2018.06.032_bib0005","first-page":"1","article-title":"World Alzheimer report 2016 improving healthcare for people living with dementia. Coverage, quality and costs now and in the future","author":"Prince","year":"2016","journal-title":"Alzheimer's Dis. Int."},{"key":"10.1016\/j.bbr.2018.06.032_bib0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2018.06.032_bib0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","article-title":"Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society","volume":"15","author":"Winblad","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbr.2018.06.032_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mppsy.2007.11.009","article-title":"The molecular pathology of Alzheimer\u2019s disease","volume":"7","author":"Yates","year":"2008","journal-title":"Psychiatry"},{"key":"10.1016\/j.bbr.2018.06.032_bib0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbr.2018.06.032_bib0030","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in alzheimer patients compared to normal controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2018.06.032_bib0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/WNL.46.1.130","article-title":"The spectrum of behavioral changes in Alzheimer\u2019s disease","volume":"46","author":"Mega","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2018.06.032_bib0040","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1038\/emm.2014.121","article-title":"Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease","volume":"47","author":"Musiek","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbr.2018.06.032_bib0045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2018.06.032_bib0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.maturitas.2014.05.009","article-title":"Depression and dementia: cause, consequence or coincidence?","volume":"79","author":"Bennett","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.bbr.2018.06.032_bib0055","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/gps.1763","article-title":"Possible therapeutic implication of a?? disturbances in depression [2]","volume":"22","author":"Pomara","year":"2007","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.bbr.2018.06.032_bib0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40266-012-0012-5","article-title":"Effect of selective serotonin reuptake inhibitors in Alzheimer\u2019s disease with comorbid depression: a meta-analysis of depression and cognitive outcomes","volume":"29","author":"Sepehry","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bbr.2018.06.032_bib0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pnpbp.2012.12.016","article-title":"Heterogeneity of elderly depression: Increased risk of Alzheimer\u2019s disease and Abeta protein metabolism","volume":"43","author":"Namekawa","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2018.06.032_bib0070","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1476-5381.2010.00669.x","article-title":"Soluble beta amyloid 1-42: a critical player in producing behavioural and biochemical changes evoking depressive-related state?","volume":"159","author":"Colaianna","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2018.06.032_bib0075","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mp.2012.168","article-title":"Amyloid-\u03b2 oligomers link depressive-like behavior and cognitive deficits in mice","volume":"18","author":"Ledo","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbr.2018.06.032_bib0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2013.01.039","article-title":"Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-\u03b2 (A\u03b21-40) administration in mice","volume":"244","author":"dos Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.06.032_bib0085","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","article-title":"Lipid peroxidation and protein oxidation in Alzheimer\u2019s disease brain: potential causes and consequences involving amyloid \u03b2-peptide-associated free radical oxidative stress","volume":"32","author":"Butterfield","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbr.2018.06.032_bib0090","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10571-014-0074-5","article-title":"Parallels between Major depressive disorder and Alzheimer\u2019s disease: role of oxidative stress and genetic vulnerability","volume":"34","author":"Rodrigues","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2018.06.032_bib0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12640-015-9540-1","article-title":"Effects of agmatine on depressive-like behavior induced by intracerebroventricular administration of 1-methyl-4-phenylpyridinium (MPP+)","volume":"28","author":"Moretti","year":"2015","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbr.2018.06.032_bib0100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2741\/710","article-title":"Role of agmatine in neurodegenerative diseases and epilepsy","volume":"6","author":"Moretti","year":"2014","journal-title":"Front. Biosci. (Elite Ed)"},{"key":"10.1016\/j.bbr.2018.06.032_bib0105","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/0024-3205(95)00226-V","article-title":"Agmatine, the bacterial amine, is widely distributed in mammalian tissues","volume":"56","author":"Raasch","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2018.06.032_bib0110","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine metabolic pathway and spectrum of activity in brain","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2018.06.032_bib0115","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","article-title":"Agmatine: clinical applications after 100 years in translation","volume":"18","author":"Piletz","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbr.2018.06.032_bib0120","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1042\/BCJ20170007","article-title":"Agmatine: multifunctional arginine metabolite and magic bullet in clinical neuroscience?","volume":"474","author":"Laube","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbr.2018.06.032_bib0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1196\/annals.1304.014","article-title":"Is agmatine an endogenous anxiolytic\/antidepressant agent?","author":"Aricioglu","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbr.2018.06.032_bib0130","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.euroneuro.2016.10.013","article-title":"Agmatine, a potential novel therapeutic strategy for depression","volume":"26","author":"Freitas","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2018.06.032_bib0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1749-6632.1999.tb09392.x","article-title":"Plasma agmatine and platelet imidazoline receptors in depression","author":"Halaris","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbr.2018.06.032_bib0140","first-page":"274","article-title":"Nitric oxide branch of arginine metabolism in depression: effect of venlafaxine","volume":"2","author":"Piletz","year":"2009","journal-title":"Intl J Heal. Sci."},{"key":"10.1016\/j.bbr.2018.06.032_bib0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1601-5215.2012.00675.x","article-title":"The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study","volume":"25","author":"Shopsin","year":"2013","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.bbr.2018.06.032_bib0150","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.neuroscience.2010.05.004","article-title":"Agmatine protects against beta-amyloid25-35-induced memory impairments in the rat","volume":"169","author":"Bergin","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2018.06.032_bib0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2011.07.054","article-title":"Pre-aggregated Abeta(25-35) alters arginine metabolism in the rat hippocampus and prefrontal cortex","volume":"193","author":"Liu","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2018.06.032_bib0160","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","article-title":"Altered arginine metabolism in Alzheimer\u2019s disease brains","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2018.06.032_bib0165","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jalz.2015.06.1721","article-title":"Arginine decarboxylase and agmatinase immunoreactivity in Alzheimer\u2019s superior frontal gyrus, Alzheimer\u2019s Dement","volume":"11","author":"Cinco","year":"2015","journal-title":"J. Alzheimer\u2019s Assoc."},{"key":"10.1016\/j.bbr.2018.06.032_bib0170","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3349\/ymj.2014.55.3.689","article-title":"Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model","volume":"55","author":"Song","year":"2014","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.bbr.2018.06.032_bib0175","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuropharm.2016.10.029","article-title":"Agmatine ameliorates type 2 diabetes induced-Alzheimer\u2019s disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling","volume":"113","author":"Kang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2018.06.032_bib0180","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1523\/JNEUROSCI.5047-06.2007","article-title":"Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer\u2019s disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein","volume":"27","author":"Medeiros","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2018.06.032_bib0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbr.2006.11.032","article-title":"Differential susceptibility following \u03b2-amyloid peptide-(1-40) administration in C57BL\/6 and Swiss albino mice: evidence for a dissociation between cognitive deficits and the glutathione system response","volume":"177","author":"Prediger","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.06.032_bib0190","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/382716a0","article-title":"Scavenger receptor-mediated adhesion of microglia to \u03b2-amyloid fibrils","volume":"382","author":"El Khoury","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2018.06.032_bib0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","article-title":"Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.bbr.2018.06.032_bib0200","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0160-5402(86)90038-0","article-title":"Intracerebroventricular injections in mice. Some methodological refinements","volume":"16","author":"Laursen","year":"1986","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.bbr.2018.06.032_bib0205","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004"},{"key":"10.1016\/j.bbr.2018.06.032_bib0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2013.10.041","article-title":"Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice","volume":"720","author":"Taksande","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2018.06.032_bib0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"LOWRY","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2018.06.032_bib0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbr.2018.06.032_bib0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbr.2018.06.032_bib0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"[13] catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbr.2018.06.032_bib0235","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0076-6879(85)13062-4","article-title":"Glutathione reductase","volume":"113","author":"Carlberg","year":"1985","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbr.2018.06.032_bib0240","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0076-6879(81)77046-0","article-title":"Glutathione Peroxidase","volume":"77","author":"Wendel","year":"1981","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbr.2018.06.032_bib0245","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.bbr.2018.06.032_bib0250","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","article-title":"Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity","volume":"57","author":"Porsolt","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2018.06.032_bib0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2014.12.009","article-title":"Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice","volume":"130","author":"Neis","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2018.06.032_bib0260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jagp.2015.12.003","article-title":"Amyloid hypothesis: Is there a role for antiamyloid treatment in late-life depression?","volume":"24","author":"Mahgoub","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.bbr.2018.06.032_bib0265","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.psychres.2017.10.008","article-title":"Glucocorticoid may influence amyloid \u03b2 metabolism in patients with depression","volume":"259","author":"Ishijima","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbr.2018.06.032_bib0270","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2010.03.052","article-title":"Altered emotionality leads to increased pain tolerance in amyloid \u03b2 (A\u03b21-40) peptide-treated mice","volume":"212","author":"Pamplona","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.06.032_bib0275","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbr.2018.06.032_bib0280","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mds.1099","article-title":"Comorbidity of the nonmotor symptoms of Parkinson\u2019s disease","volume":"16","author":"Shulman","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2018.06.032_bib0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-0327(00)00199-3","article-title":"Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments","volume":"64","author":"Bilici","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbr.2018.06.032_bib0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-200403000-00006","article-title":"Antioxidant enzyme activities and oxidative stress in affective disorders","volume":"19","author":"Ozcan","year":"2004","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2018.06.032_bib0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3999(03)00567-1","article-title":"Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids","volume":"56","author":"Tsuboi","year":"2004","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.bbr.2018.06.032_bib0300","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/0019-5545.102424","article-title":"Role of antioxidants in generalised anxiety disorder and depression","volume":"54","author":"Gautam","year":"2012","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.bbr.2018.06.032_bib0305","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s11064-007-9289-x","article-title":"Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain","volume":"32","author":"Eren","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2018.06.032_bib0310","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bbadis.2006.03.002","article-title":"Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer\u2019s disease","volume":"1762","author":"Ono","year":"2006","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.bbr.2018.06.032_bib0315","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-2010-101320","article-title":"Folic acid plus \u03b1-tocopherol mitigates amyloid-\u03b2-induced neurotoxicity through modulation of mitochondrial complexes activity","volume":"24","author":"Figueiredo","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.bbr.2018.06.032_bib0320","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pnpbp.2013.12.012","article-title":"Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice","volume":"50","author":"Freitas","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2018.06.032_bib0325","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1007\/s12035-015-9182-6","article-title":"Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice","volume":"53","author":"Freitas","year":"2016","journal-title":"Mol. Neurobiol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818303759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818303759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T18:05:15Z","timestamp":1661537115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432818303759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":65,"alternative-id":["S0166432818303759"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2018.06.032","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid \u03b2 (A\u03b21-40) administration in mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2018.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}